[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Herpes Marker Testing Market 2022 by Company, Regions, Type and Application, Forecast to 2028

July 2022 | 110 pages | ID: G1D4DF055680EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Herpes Marker Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Herpes Marker Testing market size is estimated to be worth US$ 76 million in 2021 and is forecast to a readjusted size of USD 95 million by 2028 with a CAGR of 3.1% during review period. Research accounting for % of the Herpes Marker Testing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While HSV-1 segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Herpes Marker Testing include Abbott Laboratories, Abcam Plc, BioM?rieux SA, Thermo Fisher Scientific, Inc., and F. Hoffmann-La Roche Ltd., etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Herpes Marker Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
  • HSV-1
  • HSV-2
  • HSV-1/ HSV-2
Market segment by Application, can be divided into
  • Research
  • Clinic
Market segment by players, this report covers
  • Abbott Laboratories
  • Abcam Plc
  • BioM?rieux SA
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • DiaSorin S.p.A.
  • Quidel Corporation
  • Luminex Corporation
  • Merck KGaA
  • Qiagen N.V.
  • Norgen Biotek Corp.
  • Hologic Inc.
  • Bio Rad Laboratories Inc.
  • Meridian Bioscience Inc
  • Teco Diagnostics
Market segment by regions, regional analysis covers
  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Herpes Marker Testing product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Herpes Marker Testing, with revenue, gross margin and global market share of Herpes Marker Testing from 2019 to 2022.

Chapter 3, the Herpes Marker Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Herpes Marker Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Herpes Marker Testing research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Herpes Marker Testing
1.2 Classification of Herpes Marker Testing by Type
  1.2.1 Overview: Global Herpes Marker Testing Market Size by Type: 2017 Versus 2021 Versus 2028
  1.2.2 Global Herpes Marker Testing Revenue Market Share by Type in 2021
  1.2.3 HSV-1
  1.2.4 HSV-2
  1.2.5 HSV-1/ HSV-2
1.3 Global Herpes Marker Testing Market by Application
  1.3.1 Overview: Global Herpes Marker Testing Market Size by Application: 2017 Versus 2021 Versus 2028
  1.3.2 Research
  1.3.3 Clinic
1.4 Global Herpes Marker Testing Market Size & Forecast
1.5 Global Herpes Marker Testing Market Size and Forecast by Region
  1.5.1 Global Herpes Marker Testing Market Size by Region: 2017 VS 2021 VS 2028
  1.5.2 Global Herpes Marker Testing Market Size by Region, (2017-2022)
  1.5.3 North America Herpes Marker Testing Market Size and Prospect (2017-2028)
  1.5.4 Europe Herpes Marker Testing Market Size and Prospect (2017-2028)
  1.5.5 Asia-Pacific Herpes Marker Testing Market Size and Prospect (2017-2028)
  1.5.6 South America Herpes Marker Testing Market Size and Prospect (2017-2028)
  1.5.7 Middle East and Africa Herpes Marker Testing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
  1.6.1 Herpes Marker Testing Market Drivers
  1.6.2 Herpes Marker Testing Market Restraints
  1.6.3 Herpes Marker Testing Trends Analysis

2 COMPANY PROFILES

2.1 Abbott Laboratories
  2.1.1 Abbott Laboratories Details
  2.1.2 Abbott Laboratories Major Business
  2.1.3 Abbott Laboratories Herpes Marker Testing Product and Solutions
  2.1.4 Abbott Laboratories Herpes Marker Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Abcam Plc
  2.2.1 Abcam Plc Details
  2.2.2 Abcam Plc Major Business
  2.2.3 Abcam Plc Herpes Marker Testing Product and Solutions
  2.2.4 Abcam Plc Herpes Marker Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.2.5 Abcam Plc Recent Developments and Future Plans
2.3 BioM?rieux SA
  2.3.1 BioM?rieux SA Details
  2.3.2 BioM?rieux SA Major Business
  2.3.3 BioM?rieux SA Herpes Marker Testing Product and Solutions
  2.3.4 BioM?rieux SA Herpes Marker Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.3.5 BioM?rieux SA Recent Developments and Future Plans
2.4 Thermo Fisher Scientific, Inc.
  2.4.1 Thermo Fisher Scientific, Inc. Details
  2.4.2 Thermo Fisher Scientific, Inc. Major Business
  2.4.3 Thermo Fisher Scientific, Inc. Herpes Marker Testing Product and Solutions
  2.4.4 Thermo Fisher Scientific, Inc. Herpes Marker Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.4.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
2.5 F. Hoffmann-La Roche Ltd.
  2.5.1 F. Hoffmann-La Roche Ltd. Details
  2.5.2 F. Hoffmann-La Roche Ltd. Major Business
  2.5.3 F. Hoffmann-La Roche Ltd. Herpes Marker Testing Product and Solutions
  2.5.4 F. Hoffmann-La Roche Ltd. Herpes Marker Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.5.5 F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
2.6 DiaSorin S.p.A.
  2.6.1 DiaSorin S.p.A. Details
  2.6.2 DiaSorin S.p.A. Major Business
  2.6.3 DiaSorin S.p.A. Herpes Marker Testing Product and Solutions
  2.6.4 DiaSorin S.p.A. Herpes Marker Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.6.5 DiaSorin S.p.A. Recent Developments and Future Plans
2.7 Quidel Corporation
  2.7.1 Quidel Corporation Details
  2.7.2 Quidel Corporation Major Business
  2.7.3 Quidel Corporation Herpes Marker Testing Product and Solutions
  2.7.4 Quidel Corporation Herpes Marker Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.7.5 Quidel Corporation Recent Developments and Future Plans
2.8 Luminex Corporation
  2.8.1 Luminex Corporation Details
  2.8.2 Luminex Corporation Major Business
  2.8.3 Luminex Corporation Herpes Marker Testing Product and Solutions
  2.8.4 Luminex Corporation Herpes Marker Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.8.5 Luminex Corporation Recent Developments and Future Plans
2.9 Merck KGaA
  2.9.1 Merck KGaA Details
  2.9.2 Merck KGaA Major Business
  2.9.3 Merck KGaA Herpes Marker Testing Product and Solutions
  2.9.4 Merck KGaA Herpes Marker Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.9.5 Merck KGaA Recent Developments and Future Plans
2.10 Qiagen N.V.
  2.10.1 Qiagen N.V. Details
  2.10.2 Qiagen N.V. Major Business
  2.10.3 Qiagen N.V. Herpes Marker Testing Product and Solutions
  2.10.4 Qiagen N.V. Herpes Marker Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.10.5 Qiagen N.V. Recent Developments and Future Plans
2.11 Norgen Biotek Corp.
  2.11.1 Norgen Biotek Corp. Details
  2.11.2 Norgen Biotek Corp. Major Business
  2.11.3 Norgen Biotek Corp. Herpes Marker Testing Product and Solutions
  2.11.4 Norgen Biotek Corp. Herpes Marker Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.11.5 Norgen Biotek Corp. Recent Developments and Future Plans
2.12 Hologic Inc.
  2.12.1 Hologic Inc. Details
  2.12.2 Hologic Inc. Major Business
  2.12.3 Hologic Inc. Herpes Marker Testing Product and Solutions
  2.12.4 Hologic Inc. Herpes Marker Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.12.5 Hologic Inc. Recent Developments and Future Plans
2.13 Bio Rad Laboratories Inc.
  2.13.1 Bio Rad Laboratories Inc. Details
  2.13.2 Bio Rad Laboratories Inc. Major Business
  2.13.3 Bio Rad Laboratories Inc. Herpes Marker Testing Product and Solutions
  2.13.4 Bio Rad Laboratories Inc. Herpes Marker Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.13.5 Bio Rad Laboratories Inc. Recent Developments and Future Plans
2.14 Meridian Bioscience Inc
  2.14.1 Meridian Bioscience Inc Details
  2.14.2 Meridian Bioscience Inc Major Business
  2.14.3 Meridian Bioscience Inc Herpes Marker Testing Product and Solutions
  2.14.4 Meridian Bioscience Inc Herpes Marker Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.14.5 Meridian Bioscience Inc Recent Developments and Future Plans
2.15 Teco Diagnostics
  2.15.1 Teco Diagnostics Details
  2.15.2 Teco Diagnostics Major Business
  2.15.3 Teco Diagnostics Herpes Marker Testing Product and Solutions
  2.15.4 Teco Diagnostics Herpes Marker Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.15.5 Teco Diagnostics Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Herpes Marker Testing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
  3.2.1 Top 3 Herpes Marker Testing Players Market Share in 2021
  3.2.2 Top 10 Herpes Marker Testing Players Market Share in 2021
  3.2.3 Market Competition Trend
3.3 Herpes Marker Testing Players Head Office, Products and Services Provided
3.4 Herpes Marker Testing Mergers & Acquisitions
3.5 Herpes Marker Testing New Entrants and Expansion Plans

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Herpes Marker Testing Revenue and Market Share by Type (2017-2022)
4.2 Global Herpes Marker Testing Market Forecast by Type (2023-2028)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Herpes Marker Testing Revenue Market Share by Application (2017-2022)
5.2 Global Herpes Marker Testing Market Forecast by Application (2023-2028)

6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION

6.1 North America Herpes Marker Testing Revenue by Type (2017-2028)
6.2 North America Herpes Marker Testing Revenue by Application (2017-2028)
6.3 North America Herpes Marker Testing Market Size by Country
  6.3.1 North America Herpes Marker Testing Revenue by Country (2017-2028)
  6.3.2 United States Herpes Marker Testing Market Size and Forecast (2017-2028)
  6.3.3 Canada Herpes Marker Testing Market Size and Forecast (2017-2028)
  6.3.4 Mexico Herpes Marker Testing Market Size and Forecast (2017-2028)

7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION

7.1 Europe Herpes Marker Testing Revenue by Type (2017-2028)
7.2 Europe Herpes Marker Testing Revenue by Application (2017-2028)
7.3 Europe Herpes Marker Testing Market Size by Country
  7.3.1 Europe Herpes Marker Testing Revenue by Country (2017-2028)
  7.3.2 Germany Herpes Marker Testing Market Size and Forecast (2017-2028)
  7.3.3 France Herpes Marker Testing Market Size and Forecast (2017-2028)
  7.3.4 United Kingdom Herpes Marker Testing Market Size and Forecast (2017-2028)
  7.3.5 Russia Herpes Marker Testing Market Size and Forecast (2017-2028)
  7.3.6 Italy Herpes Marker Testing Market Size and Forecast (2017-2028)

8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION

8.1 Asia-Pacific Herpes Marker Testing Revenue by Type (2017-2028)
8.2 Asia-Pacific Herpes Marker Testing Revenue by Application (2017-2028)
8.3 Asia-Pacific Herpes Marker Testing Market Size by Region
  8.3.1 Asia-Pacific Herpes Marker Testing Revenue by Region (2017-2028)
  8.3.2 China Herpes Marker Testing Market Size and Forecast (2017-2028)
  8.3.3 Japan Herpes Marker Testing Market Size and Forecast (2017-2028)
  8.3.4 South Korea Herpes Marker Testing Market Size and Forecast (2017-2028)
  8.3.5 India Herpes Marker Testing Market Size and Forecast (2017-2028)
  8.3.6 Southeast Asia Herpes Marker Testing Market Size and Forecast (2017-2028)
  8.3.7 Australia Herpes Marker Testing Market Size and Forecast (2017-2028)

9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION

9.1 South America Herpes Marker Testing Revenue by Type (2017-2028)
9.2 South America Herpes Marker Testing Revenue by Application (2017-2028)
9.3 South America Herpes Marker Testing Market Size by Country
  9.3.1 South America Herpes Marker Testing Revenue by Country (2017-2028)
  9.3.2 Brazil Herpes Marker Testing Market Size and Forecast (2017-2028)
  9.3.3 Argentina Herpes Marker Testing Market Size and Forecast (2017-2028)

10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION

10.1 Middle East & Africa Herpes Marker Testing Revenue by Type (2017-2028)
10.2 Middle East & Africa Herpes Marker Testing Revenue by Application (2017-2028)
10.3 Middle East & Africa Herpes Marker Testing Market Size by Country
  10.3.1 Middle East & Africa Herpes Marker Testing Revenue by Country (2017-2028)
  10.3.2 Turkey Herpes Marker Testing Market Size and Forecast (2017-2028)
  10.3.3 Saudi Arabia Herpes Marker Testing Market Size and Forecast (2017-2028)
  10.3.4 UAE Herpes Marker Testing Market Size and Forecast (2017-2028)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

LIST OF TABLES

Table 1. Global Herpes Marker Testing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Herpes Marker Testing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Herpes Marker Testing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Herpes Marker Testing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Herpes Marker Testing Revenue Market Share by Region (2023-2028)
Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Laboratories Major Business
Table 8. Abbott Laboratories Herpes Marker Testing Product and Solutions
Table 9. Abbott Laboratories Herpes Marker Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Abcam Plc Corporate Information, Head Office, and Major Competitors
Table 11. Abcam Plc Major Business
Table 12. Abcam Plc Herpes Marker Testing Product and Solutions
Table 13. Abcam Plc Herpes Marker Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. BioM?rieux SA Corporate Information, Head Office, and Major Competitors
Table 15. BioM?rieux SA Major Business
Table 16. BioM?rieux SA Herpes Marker Testing Product and Solutions
Table 17. BioM?rieux SA Herpes Marker Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Thermo Fisher Scientific, Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Thermo Fisher Scientific, Inc. Major Business
Table 20. Thermo Fisher Scientific, Inc. Herpes Marker Testing Product and Solutions
Table 21. Thermo Fisher Scientific, Inc. Herpes Marker Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. F. Hoffmann-La Roche Ltd. Corporate Information, Head Office, and Major Competitors
Table 23. F. Hoffmann-La Roche Ltd. Major Business
Table 24. F. Hoffmann-La Roche Ltd. Herpes Marker Testing Product and Solutions
Table 25. F. Hoffmann-La Roche Ltd. Herpes Marker Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. DiaSorin S.p.A. Corporate Information, Head Office, and Major Competitors
Table 27. DiaSorin S.p.A. Major Business
Table 28. DiaSorin S.p.A. Herpes Marker Testing Product and Solutions
Table 29. DiaSorin S.p.A. Herpes Marker Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Quidel Corporation Corporate Information, Head Office, and Major Competitors
Table 31. Quidel Corporation Major Business
Table 32. Quidel Corporation Herpes Marker Testing Product and Solutions
Table 33. Quidel Corporation Herpes Marker Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Luminex Corporation Corporate Information, Head Office, and Major Competitors
Table 35. Luminex Corporation Major Business
Table 36. Luminex Corporation Herpes Marker Testing Product and Solutions
Table 37. Luminex Corporation Herpes Marker Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Merck KGaA Corporate Information, Head Office, and Major Competitors
Table 39. Merck KGaA Major Business
Table 40. Merck KGaA Herpes Marker Testing Product and Solutions
Table 41. Merck KGaA Herpes Marker Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Qiagen N.V. Corporate Information, Head Office, and Major Competitors
Table 43. Qiagen N.V. Major Business
Table 44. Qiagen N.V. Herpes Marker Testing Product and Solutions
Table 45. Qiagen N.V. Herpes Marker Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Norgen Biotek Corp. Corporate Information, Head Office, and Major Competitors
Table 47. Norgen Biotek Corp. Major Business
Table 48. Norgen Biotek Corp. Herpes Marker Testing Product and Solutions
Table 49. Norgen Biotek Corp. Herpes Marker Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Hologic Inc. Corporate Information, Head Office, and Major Competitors
Table 51. Hologic Inc. Major Business
Table 52. Hologic Inc. Herpes Marker Testing Product and Solutions
Table 53. Hologic Inc. Herpes Marker Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Bio Rad Laboratories Inc. Corporate Information, Head Office, and Major Competitors
Table 55. Bio Rad Laboratories Inc. Major Business
Table 56. Bio Rad Laboratories Inc. Herpes Marker Testing Product and Solutions
Table 57. Bio Rad Laboratories Inc. Herpes Marker Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Meridian Bioscience Inc Corporate Information, Head Office, and Major Competitors
Table 59. Meridian Bioscience Inc Major Business
Table 60. Meridian Bioscience Inc Herpes Marker Testing Product and Solutions
Table 61. Meridian Bioscience Inc Herpes Marker Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Teco Diagnostics Corporate Information, Head Office, and Major Competitors
Table 63. Teco Diagnostics Major Business
Table 64. Teco Diagnostics Herpes Marker Testing Product and Solutions
Table 65. Teco Diagnostics Herpes Marker Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Global Herpes Marker Testing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 67. Global Herpes Marker Testing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 68. Breakdown of Herpes Marker Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Herpes Marker Testing Players Head Office, Products and Services Provided
Table 70. Herpes Marker Testing Mergers & Acquisitions in the Past Five Years
Table 71. Herpes Marker Testing New Entrants and Expansion Plans
Table 72. Global Herpes Marker Testing Revenue (USD Million) by Type (2017-2022)
Table 73. Global Herpes Marker Testing Revenue Share by Type (2017-2022)
Table 74. Global Herpes Marker Testing Revenue Forecast by Type (2023-2028)
Table 75. Global Herpes Marker Testing Revenue by Application (2017-2022)
Table 76. Global Herpes Marker Testing Revenue Forecast by Application (2023-2028)
Table 77. North America Herpes Marker Testing Revenue by Type (2017-2022) & (USD Million)
Table 78. North America Herpes Marker Testing Revenue by Type (2023-2028) & (USD Million)
Table 79. North America Herpes Marker Testing Revenue by Application (2017-2022) & (USD Million)
Table 80. North America Herpes Marker Testing Revenue by Application (2023-2028) & (USD Million)
Table 81. North America Herpes Marker Testing Revenue by Country (2017-2022) & (USD Million)
Table 82. North America Herpes Marker Testing Revenue by Country (2023-2028) & (USD Million)
Table 83. Europe Herpes Marker Testing Revenue by Type (2017-2022) & (USD Million)
Table 84. Europe Herpes Marker Testing Revenue by Type (2023-2028) & (USD Million)
Table 85. Europe Herpes Marker Testing Revenue by Application (2017-2022) & (USD Million)
Table 86. Europe Herpes Marker Testing Revenue by Application (2023-2028) & (USD Million)
Table 87. Europe Herpes Marker Testing Revenue by Country (2017-2022) & (USD Million)
Table 88. Europe Herpes Marker Testing Revenue by Country (2023-2028) & (USD Million)
Table 89. Asia-Pacific Herpes Marker Testing Revenue by Type (2017-2022) & (USD Million)
Table 90. Asia-Pacific Herpes Marker Testing Revenue by Type (2023-2028) & (USD Million)
Table 91. Asia-Pacific Herpes Marker Testing Revenue by Application (2017-2022) & (USD Million)
Table 92. Asia-Pacific Herpes Marker Testing Revenue by Application (2023-2028) & (USD Million)
Table 93. Asia-Pacific Herpes Marker Testing Revenue by Region (2017-2022) & (USD Million)
Table 94. Asia-Pacific Herpes Marker Testing Revenue by Region (2023-2028) & (USD Million)
Table 95. South America Herpes Marker Testing Revenue by Type (2017-2022) & (USD Million)
Table 96. South America Herpes Marker Testing Revenue by Type (2023-2028) & (USD Million)
Table 97. South America Herpes Marker Testing Revenue by Application (2017-2022) & (USD Million)
Table 98. South America Herpes Marker Testing Revenue by Application (2023-2028) & (USD Million)
Table 99. South America Herpes Marker Testing Revenue by Country (2017-2022) & (USD Million)
Table 100. South America Herpes Marker Testing Revenue by Country (2023-2028) & (USD Million)
Table 101. Middle East & Africa Herpes Marker Testing Revenue by Type (2017-2022) & (USD Million)
Table 102. Middle East & Africa Herpes Marker Testing Revenue by Type (2023-2028) & (USD Million)
Table 103. Middle East & Africa Herpes Marker Testing Revenue by Application (2017-2022) & (USD Million)
Table 104. Middle East & Africa Herpes Marker Testing Revenue by Application (2023-2028) & (USD Million)
Table 105. Middle East & Africa Herpes Marker Testing Revenue by Country (2017-2022) & (USD Million)
Table 106. Middle East & Africa Herpes Marker Testing Revenue by Country (2023-2028) & (USD Million)

LIST OF FIGURES

Figure 1. Herpes Marker Testing Picture
Figure 2. Global Herpes Marker Testing Revenue Market Share by Type in 2021
Figure 3. HSV-1
Figure 4. HSV-2
Figure 5. HSV-1/ HSV-2
Figure 6. Herpes Marker Testing Revenue Market Share by Application in 2021
Figure 7. Research Picture
Figure 8. Clinic Picture
Figure 9. Global Herpes Marker Testing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Herpes Marker Testing Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Herpes Marker Testing Revenue Market Share by Region (2017-2028)
Figure 12. Global Herpes Marker Testing Revenue Market Share by Region in 2021
Figure 13. North America Herpes Marker Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Herpes Marker Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Herpes Marker Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Herpes Marker Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Herpes Marker Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Herpes Marker Testing Market Drivers
Figure 19. Herpes Marker Testing Market Restraints
Figure 20. Herpes Marker Testing Market Trends
Figure 21. Abbott Laboratories Recent Developments and Future Plans
Figure 22. Abcam Plc Recent Developments and Future Plans
Figure 23. BioM?rieux SA Recent Developments and Future Plans
Figure 24. Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
Figure 25. F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
Figure 26. DiaSorin S.p.A. Recent Developments and Future Plans
Figure 27. Quidel Corporation Recent Developments and Future Plans
Figure 28. Luminex Corporation Recent Developments and Future Plans
Figure 29. Merck KGaA Recent Developments and Future Plans
Figure 30. Qiagen N.V. Recent Developments and Future Plans
Figure 31. Norgen Biotek Corp. Recent Developments and Future Plans
Figure 32. Hologic Inc. Recent Developments and Future Plans
Figure 33. Bio Rad Laboratories Inc. Recent Developments and Future Plans
Figure 34. Meridian Bioscience Inc Recent Developments and Future Plans
Figure 35. Teco Diagnostics Recent Developments and Future Plans
Figure 36. Global Herpes Marker Testing Revenue Share by Players in 2021
Figure 37. Herpes Marker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 38. Global Top 3 Players Herpes Marker Testing Revenue Market Share in 2021
Figure 39. Global Top 10 Players Herpes Marker Testing Revenue Market Share in 2021
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 41. Global Herpes Marker Testing Revenue Share by Type in 2021
Figure 42. Global Herpes Marker Testing Market Share Forecast by Type (2023-2028)
Figure 43. Global Herpes Marker Testing Revenue Share by Application in 2021
Figure 44. Global Herpes Marker Testing Market Share Forecast by Application (2023-2028)
Figure 45. North America Herpes Marker Testing Sales Market Share by Type (2017-2028)
Figure 46. North America Herpes Marker Testing Sales Market Share by Application (2017-2028)
Figure 47. North America Herpes Marker Testing Revenue Market Share by Country (2017-2028)
Figure 48. United States Herpes Marker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Canada Herpes Marker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Mexico Herpes Marker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Europe Herpes Marker Testing Sales Market Share by Type (2017-2028)
Figure 52. Europe Herpes Marker Testing Sales Market Share by Application (2017-2028)
Figure 53. Europe Herpes Marker Testing Revenue Market Share by Country (2017-2028)
Figure 54. Germany Herpes Marker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. France Herpes Marker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. United Kingdom Herpes Marker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Russia Herpes Marker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Italy Herpes Marker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Asia-Pacific Herpes Marker Testing Sales Market Share by Type (2017-2028)
Figure 60. Asia-Pacific Herpes Marker Testing Sales Market Share by Application (2017-2028)
Figure 61. Asia-Pacific Herpes Marker Testing Revenue Market Share by Region (2017-2028)
Figure 62. China Herpes Marker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Herpes Marker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South Korea Herpes Marker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Herpes Marker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Herpes Marker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Herpes Marker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Herpes Marker Testing Sales Market Share by Type (2017-2028)
Figure 69. South America Herpes Marker Testing Sales Market Share by Application (2017-2028)
Figure 70. South America Herpes Marker Testing Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Herpes Marker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Herpes Marker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East and Africa Herpes Marker Testing Sales Market Share by Type (2017-2028)
Figure 74. Middle East and Africa Herpes Marker Testing Sales Market Share by Application (2017-2028)
Figure 75. Middle East and Africa Herpes Marker Testing Revenue Market Share by Country (2017-2028)
Figure 76. Turkey Herpes Marker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Herpes Marker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. UAE Herpes Marker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source


More Publications